Stockreport

INVESTOR ALERT: Edelson Lechtzin LLP Urges Marinus Pharmaceuticals, Inc. (NASDAQ: MRNS) Shareholders to Consult Counsel About the Pending Securities Fraud Class Action

Marinus Pharmaceuticals, Inc.  (MRNS) 
Last marinus pharmaceuticals, inc. earnings: 11/6 07:30 am Check Earnings Report
US:NASDAQ Investor Relations: ir.marinuspharma.com/investor-relations
PDF NEWTOWN, Pa., June 14, 2024 (GLOBE NEWSWIRE) -- Edelson Lechtzin LLP, a leading class action law firm, is investigating securities fraud claims on behalf of all invest [Read more]